Horizon Kinetics Asset Management LLC Beam Therapeutics Inc. Transaction History
Horizon Kinetics Asset Management LLC
- $6.97 Billion
- Q3 2025
A detailed history of Horizon Kinetics Asset Management LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 9,597 shares of BEAM stock, worth $208,446. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,597Holding current value
$208,446% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding BEAM
# of Institutions
253Shares Held
98.2MCall Options Held
748KPut Options Held
619K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$240 Million1.88% of portfolio
-
Farallon Capital Management LLC San Francisco, CA10.1MShares$219 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.25MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$166 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.83MShares$105 Million0.07% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.53B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...